iSpecimen Inc

For the period ended Dec 31, 2023. Filed Mar 13, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 13, 2024

ISPC$0.79-3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 16. Form10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 13, 2024.

	iSPECIMEN, INC.

	By:	/s/ Tracy Curley
		Tracy Curley
		Chief Executive Officer, Chief Financial Officer and Treasurer(Principal Executive Officer and Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on March 13, 2024, by the following persons on behalf of the registrant and in the capacities indicated:


Signature

/s/ Tracy Curley		Chief Executive Officer, Chief Financial Officer, Treasurer and Director
Tracy Curley		(Principal Executive Officer and Principal Financial and Accounting Officer)

/s/ Andrew L. Ross
Andrew L. Ross		Director and Chairman of the Board

/s/ Theresa Mock
Theresa Mock		Director

/s/ Steven Gullans
Steven Gullans		Director

/s/ John L. Brooks III
John L. Brooks III		Director

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.